We are pleased to announce that late-breaking poster abstract submission for the 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026) is now possible!
Submission for poster presentations is open to all, and we warmly encourage everyone to share their work through a poster abstract and participate actively in the congress — your contributions continue to inspire and drive progress in our field. A contribution submitted as a poster may still be upgraded by the congress organisers to an Oral presentation if the congress adds new sessions or if it fits into sessions with missing abstracts. Every registered participant can present two posters at the ESTIV 2026 congress as first author or co-author.
IMPORTANT DEADLINES
- Late breaking poster presentations:
23 February,9 March, 23:59 CET (for all applicants) - Late breaking Notification: 16 March (at the latest)
Please read carefully the general submission guidelines below before submitting an abstract.
POSTER TOPICS
- Bio-engineering, stem cells and disease models
- Models, biomarkers and assays for endocrine disruption
- Models, biomarkers and assays for systemic and immune toxicity
- Models, biomarkers and assays for developmental toxicity
- Cardiotoxicity and cardiac efficacy models
- Local toxicity testing (safety and efficacy)
- Case studies for successful use and implementation of complex in vitro models
- Challenges in cosmetics safety
- Organ-on-a-chip & Microphysiological Systems
- Regulatory considerations for complex NAMs
- Computational toxicology – in silico modelling, read-across, artificial intelligence and machine learning
- Toxicokinetics and in vitro – in vivo extrapolation
- In vitro systems to assess respiratory toxicity
- Non-animal methods for safety testing of biopharmaceuticals/biotherapies/vaccines
- Serum free approaches
- Knowledge sharing and education
- Funding the development, validation and implementation of NAMs
- ECHA, EMA and EFSA perspectives on the use of NAMs
- In vitro and in silico methods for safety assessment of medical devices
- Role of 3R centres in the dissemination and implementation of NAMs
- Other
GENERAL GUIDELINES
- Abstracts should cover original work.
- All abstracts should be submitted via Abstract submission module. Abstracts submitted via email or all other methods will not be considered.
- There is no abstract submission fee.
- The submitter is required to ensure that all co-authors are aware of the contents of the abstract before submission.
- The same person can submit more than one abstract.
- A presenting author can present maximum two posters.
- Submission of an abstract implies formal commitment by the designated presenting author to register for the congress and to present the abstract. However, registration is not required at the time of submission.
- Abstracts can be edited/updated before the abstract submission deadline by logging in to the congress account used to submit the abstract. After the abstract submission deadline, it will no longer be possible to edit/update submitted abstracts.
- All abstracts will be evaluated by the ESTIV 2026 Scientific Committee and may be rejected or selected for oral or poster presentation.
- All abstracts accepted for presentation will be published in the abstract book and on the congress website prior to the congress.
- Please note that the corresponding author will receive all correspondence about the abstracts. For this reason, the presenting author will automatically act as the corresponding author in the system.
- Authors may submit their 2026 Congress-related work to the Virtual Special Issue ESTIV 2026, which will open in Spring 2026. Only original work which has not previously been published can be considered for publication in the special edition of TIV.
- Your abstract is not successfully submitted until you receive a confirmation email after clicking the final submit button. If you do not receive a confirmation email, please contact us: helpdesk@klinkhamergroup.com.
SUBMISSION GUIDELINES
- Abstracts must be written in English.
- Presenting author’s contact details should be included.
- Please include author and co-authors’ details including affiliation and country.
- The abstracts title should be in upper case.
- The abstracts text should be limited to 300 words.
- Any pictures, attachments or similar are not allowed/will not be displayed.
- The submission form allows you to save your abstracts as a draft in order to make changes prior submission. After the submission deadline, the latest version of your abstracts becomes the final one.